Global Osteoarthritis Drugs Market, by Drug Class (Corticosteroids, Analgesics, Phase III Drugs, Nonsteroidal Anti-Inflammatory Drugs, Hyaluronic Acid), by Route of Administration (Parenteral and Oral), by Disease Type (Hip Osteoarthritis, Shoulder Osteoarthritis, Ankle Osteoarthritis, Knee Osteoarthritis and Others), by Distribution Channel (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,), and by Region (Latin America, Europe, Asia Pacific, North America, Africa, and Middle East) was worth US$ 5,895.1 million in 2017 and is expected to grow at an annual rate of 8.2 percent from 2018 to 2026.
Request Here For PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/2580
Market participants are focusing on investing more on research and development to help the market flourish:
The market’s major players are concentrating their efforts on the research and development of novel medicines in order to meet patients’ significant unmet requirements. For example, Regeneron Pharmaceuticals began a phase III research of Fasinumab, a drug used to treat osteoarthritis, in December 2017. The research is planned to be finished in May of 2019. Furthermore, market participants’ increased focus on launching medicines for symptomatic treatment of osteoarthritis is projected to promote market growth. In Malaysia, for example, Bioventus released DUROLANE in January 2019 in collaboration with Athrotech. DUROLANE is a joint fluid osteoarthritis injection used to treat mild to moderate knee osteoarthritis.
Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2580
The market is predicted to develop due to an increase in the aging population, which is linked to osteoarthritis. According to a report published in August 2017 by the National Center for Biotechnology Information (NCBI), knee osteoarthritis accounts for over 80% of the total disease burden and affects roughly 19% of persons in the United States aged 45 and up. To grow their product range, key market players are focusing on techniques such as mergers and acquisitions. For example, in January 2016, Allergan purchased Anterios, Inc., a botulinum toxin-based prescription pharmaceutical maker.
Key Takeaways:
Because of the rising prevalence of osteoarthritis, the worldwide osteoarthritis medications market is predicted to grow at a CAGR of 8.2 percent over the forecast period. According to the National Center for Biotechnology Information (NCBI), by 2050, over 130 million people worldwide would have been diagnosed with osteoarthritis.
Because of the significant availability of NSAIDs in the market, the Nonsteroidal Anti-Inflammatory Medications (NSAIDs) segment retained a prominent position in the osteoarthritis drugs market in 2018.
The oral method of administration dominated the osteoarthritis medications market in 2018, as the bulk of the medications available for osteoarthritis are intended to be taken orally.
Because the majority of cases of osteoarthritis are reported at hospitals, the hospital pharmacies segment held a leading position in the osteoarthritis medications market in 2018.
Buy This Premium Report@ https://www.coherentmarketinsights.com/insight/buy-now/2580
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Disease Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Market Dynamics
- Global Osteoarthritis Drugs Market, By Drug Class, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Nonsteroidal Anti-Inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Hyaluronic Acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Phase III Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Osteoarthritis Drugs Market, By Route of Administration, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Osteoarthritis Drugs Market, By Disease Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Ankle Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Hip Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Knee Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Shoulder Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Osteoarthritis Drugs Market, By Distribution Channel, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Osteoarthritis Drugs Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Disease Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/osteoarthritis-drugs-market-to-surpass-us-117-billion-by-2026-1359
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837